INTEGER HOLDINGS CORPORATION Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- INTEGER HOLDINGS CORPORATION stock issued during period, value, conversion of convertible securities for the quarter ending 2026-07-03 was $0.00.
- INTEGER HOLDINGS CORPORATION stock issued during period, value, conversion of convertible securities for the quarter ending 2026-04-03 was $0.00, a 100.00% decline year-over-year.
- INTEGER HOLDINGS CORPORATION stock issued during period, value, conversion of convertible securities for the quarter ending 2025-12-31 was $0.00.
- INTEGER HOLDINGS CORPORATION stock issued during period, value, conversion of convertible securities for the quarter ending 2025-09-26 was $0.00.
- INTEGER HOLDINGS CORPORATION stock issued during period, value, conversion of convertible securities for fiscal 2025 was $183.97M.
- INTEGER HOLDINGS CORPORATION stock issued during period, value, conversion of convertible securities for fiscal 2024 was $0.00.
- INTEGER HOLDINGS CORPORATION stock issued during period, value, conversion of convertible securities for fiscal 2023 was $0.00.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2026-07-03 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $0.00 derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-04-03 | $0.00 10-Q · filed 2026-04-30 | $0.00 derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $183.97M 10-K · filed 2026-02-23 |
| 2025-09-26 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-23 | $183.97M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-27 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $183.97M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-28 | $183.97M 10-Q · filed 2026-04-30 | $183.97M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $0.00 10-K · filed 2026-02-23 |
| 2024-09-27 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-23 | |
| 2024-06-28 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-24 | |
| 2024-03-29 | $0.00 10-Q · filed 2025-04-24 | |
| 2023-12-31 | $0.00 10-K · filed 2026-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |